Discover how a team of biostatistics and pharmacokinetics experts can offer specialized guidance for clinical trial design and analysis.

Turning Data into Insights

At Worldwide Flex, we understand that clean data is the foundation of successful analyses. We are an accredited Medidata Partner and certified study builders in multiple platforms.

Computer System Validation to cover all your GMP, GLP, GCP, and QA/QC software applications. CompliancePath currently has 30+ active projects globally supporting clients in CSV/CSA compliance.

Locate sensitive information and unusual behaviors, encrypt files, and prevent data theft.

Our industry-leading clinical analytics experts build tools and solutions that efficiently facilitate data management and biometrics activities. By providing advanced services and automating technology, we're able to maximize efficiency, ease interpretation, and deliver actionable insights.

Ergomed’s Risk-Based Clinical Monitoring and Source Data Verification Approach for Data Integrity

Ergomed ensures the highest data integrity and patient safety standards through our risk-based clinical monitoring and Source Data Verification (SDV) practices. SDV is a critical process in clinical trials that ensures the data collected are accurate, complete, and verifiable against the source documents. We compare data entered into case report forms or electronic data capture systems with the source data to confirm their accuracy and reliability.

Early Phase Experts

As a full-service contract research organization, Southern Star Research has the knowledge, industry relationships and technical expertise to get your early-phase clinical trial up and running safely and efficiently.

With a broad range of experience delivering Phase 1 Healthy Volunteer, First in Human, First in Patient and Phase 2 trials, we know just how important it is for your asset to succeed in the early development lifecycle. Our experienced team will help you obtain high-quality data that will appeal to future investors, meet the requirements of international regulatory bodies such as the FDA, EMA, PMDA, and Health Canada, and prepare your product for larger Phase 3 and 4 studies, partnerships, licensing, and sale.

Whatever your clinical trial needs, we can provide a flexible, bespoke solution that will not only meet your regulatory requirements but also position your product for commercial success.

Zelta’s EDC has been used in more than 4,000 studies from startup to submission, across all phases, including over 500 phase 3c trials and 23 therapeutic areas.